조아제약
Financials
Valuation Metrics
조아제약's Market Cap is ₩104B. At end of 2025 it was ₩313B. Ranked #2381 of 2,412 in KR market (top 99%), #1605 of 1,632 on KOSDAQ (top 98%), #228 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 99%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 10.43B KRW | KR#2,381/2,412 Sec#228/231 |
| Revenue | 61.16B KRW | KR#1,688/2,412 Sec#112/231 |
| Net Income | -3.36B KRW | KR—/2,412 Sec—/231 |
| Total Assets | 73.57B KRW | KR#1,983/2,412 Sec#164/231 |
| Net Assets | 32.06B KRW | KR#2,150/2,412 Sec#192/231 |
| Employees | 279 | KR#845/2,412 Sec#72/231 |
| Value | ||
| P/B | 0.33x | KR#533/2,412 Sec#16/231 |
| P/S | 0.17x | KR#369/2,412 Sec#6/231 |
| FCF Yield | -50.64% | KR—/2,412 Sec—/231 |
| Profitability | ||
| ROE | -10.47% | KR#1,950/2,412 Sec#146/231 |
| ROA | -4.56% | KR#1,912/2,412 Sec#136/231 |
| Op. Margin | -6.76% | KR#1,912/2,412 Sec#128/231 |
| Revenue Growth | 1.50% | KR#1,421/2,412 Sec#140/231 |
| Financial Health | ||
| Debt Ratio | 129.48% | KR#1,783/2,412 Sec#198/231 |
| Total Debt | 24.54B KRW | KR#1,313/2,412 Sec#106/231 |
| FCF | -5.28B KRW | KR#1,507/2,412 Sec#120/231 |
| Cash | 2.37B KRW | KR#2,210/2,412 Sec#211/231 |
| Current Ratio | 1.10x | KR#1,596/2,412 Sec#161/231 |
| Performance | ||
| 1Y Return | -69.24% | KR#2,255/2,412 Sec#219/231 |
| 1M Return | -36.57% | KR#2,308/2,412 Sec#224/231 |
| From 52W High | -71.86% | KR#2,150/2,412 Sec#192/231 |
| 1Y MDD | -70.53% | KR#1,871/2,412 Sec#158/231 |
| Trading | ||
| Volume | 15,086 shares | KR#1,283/2,412 Sec#129/231 |
| Trading Value | 25.2M KRW | KR#1,699/2,412 Sec#187/231 |
| Foreign Own. | 0.00% | KR—/2,412 Sec—/231 |
| Per Share | ||
| EPS | -542 KRW | KR—/2,412 Sec—/231 |
| BPS | 5,175 KRW | KR#1,478/2,412 Sec#105/231 |
Company Info
Joa Pharmaceutical, established in 1996, was formed following the acquisition of Samgang Pharmaceutical Company in 1988. It operates the pharmacy franchise Medipharm as a subsidiary. The company produces and supplies over 200 pharmaceuticals and health foods, including Hepatos and Evathion, supported by over 100 Medical Representatives across 15 nationwide sales offices. Since beginning exports to Vietnam in 1995, Joa Pharmaceutical now exports over 150 product types to 23 countries, striving to become a global healthcare leader through innovative product development and brand competitiveness. Joa Pharmaceutical is headquartered in Yeongdeungpo-gu, Seoul Metropolitan City.